Literature DB >> 10821993

Anabolic-androgenic steroid use disorders among a sample of Australian competitive and recreational users.

J Copeland1, R Peters, P Dillon.   

Abstract

Illicit anabolic-androgenic steroid (AAS) use, for body building and body image purposes, is increasing internationally. This study describes the prevalence and symptoms of AAS use disorders obtained using a semi-structured interview among a mixed-gender sample of 100 current Australian users, that were recruited from a variety of sources. The median age of the sample was 27 years and 94% were male. The full range of DSM IV symptoms of AAS abuse and dependence were reported and over three quarters (78%) of the sample exhibited at least one symptom of abuse or dependence on AAS. A total of 23% of the participants qualified for a diagnosis of AAS dependence using DSM IV criteria and a further 25% met criteria for AAS abuse. There were no gender differences in AAS abuse or dependence diagnoses. The only variable related to an AAS substance use disorder was reporting the experience of AAS-related aggression, which may be a useful clinical indicator of the disorder.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10821993     DOI: 10.1016/s0376-8716(99)00141-6

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  22 in total

1.  Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2009-04-01       Impact factor: 4.492

2.  Development and validation of the appearance and performance enhancing drug use schedule.

Authors:  Tom Hildebrandt; James W Langenbucher; Justine Karmin Lai; Katharine L Loeb; Eric Hollander
Journal:  Addict Behav       Date:  2011-05-11       Impact factor: 3.913

3.  The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates.

Authors:  Harrison G Pope; Gen Kanayama; Alison Athey; Erin Ryan; James I Hudson; Aaron Baggish
Journal:  Am J Addict       Date:  2013-09-20

Review 4.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

5.  A diagnostic interview module for anabolic-androgenic steroid dependence: preliminary evidence of reliability and validity.

Authors:  Harrison G Pope; Joseph Kean; Adam Nash; Gen Kanayama; Douglas B Samuel; Warren K Bickel; James I Hudson
Journal:  Exp Clin Psychopharmacol       Date:  2010-06       Impact factor: 3.157

6.  Body image disturbance in 1000 male appearance and performance enhancing drug users.

Authors:  Tom Hildebrandt; Lauren Alfano; James W Langenbucher
Journal:  J Psychiatr Res       Date:  2010-01-27       Impact factor: 4.791

Review 7.  The diagnostic dilemma of pathological appearance and performance enhancing drug use.

Authors:  Tom Hildebrandt; Justine K Lai; James W Langenbucher; Melanie Schneider; Rachel Yehuda; Donald W Pfaff
Journal:  Drug Alcohol Depend       Date:  2010-11-05       Impact factor: 4.492

Review 8.  Anabolic steroid abuse and dependence.

Authors:  Kirk J Brower
Journal:  Curr Psychiatry Rep       Date:  2002-10       Impact factor: 5.285

Review 9.  Illicit anabolic-androgenic steroid use.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Horm Behav       Date:  2009-09-18       Impact factor: 3.587

Review 10.  Anabolic-androgenic steroid dependence: an emerging disorder.

Authors:  Gen Kanayama; Kirk J Brower; Ruth I Wood; James I Hudson; Harrison G Pope
Journal:  Addiction       Date:  2009-12       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.